Upcoming Login Downtime
We're updating the Biocentury.com platform login experience to make access more secure and reliable. As part of this update, logins will be temporarily unavailable on Sunday, March 16, from 4:00AM to 4:00PM GMT. We recognize the inconvenience and appreciate your understanding. Please check back after the maintenance period.
For updates, questions, or issues, please call us at +1 650-552-4224 or email us at support@biocentury.com.
- Company Profiles
- Target Profiles
- Product Profiles
Explore BCIQ profiles by entering a company name.
Taiho Ventures LLC
BioCentury | Oct 17, 2020
Deals
Oct. 16 Quick Takes: Dren Bio’s $60M series A; plus Roche, Synairgen, Astellas-iota and more
Dren Bio raises $60M series A to develop cell-depleting engineered proteinsDren Bio raised a $60 million series A round led by SR One and Taiho Ventures, LLC, with participation from existing
BioCentury | Jun 5, 2020
Finance
Founding investors MPM, F2 back Cullinan’s asset-centric approach with $98.5M series B
BioCentury | Jul 26, 2019
Finance
Taiho turns to incubation
The new venture arm of Japan’s Taiho will invest earlier and more broadly than its first
BioCentury | Jun 21, 2019
Financial News
June 20 Financial Quick Takes: Zymeworks raises $175M; plus Casdin, Scholar Rock and more
BioCentury | Oct 19, 2018
Finance
Taiho ups its stakes
Taiho Ventures’ upsized fund will enable the venture arm to take larger stakes
BioCentury | Oct 16, 2018
Financial News
Taiho Ventures ups investments to $300M, to focus on oncology
BioCentury | Mar 9, 2017
Finance
Pharmas learn their A, B, seeds
Analyzing the surge of newco formations involving corporate VCs
Items per page:
1 - 10 of 11